Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Donor Leukocyte Infusions (DLIs) for Recurrent Hodgkin Lymphoma (HL) Following Allogeneic Stem Cell Transplantation (allo-SCT): Ten-Year Experience at the M.D. Anderson Cancer Center

Paolo Anderlini, MD, Sandra Acholonu, Grace-Julia Okoroji, Sergio A Giralt, MD, Roy Jones, MD, PhD, Chitra M Hosing, MD, Muzaffar H Qazilbash, MD, Yago Nieto, MD, PhD, Borje S Andersson, MD, PhD, Uday R Popat, MD, Naoto T Ueno, MD, Marcos J de Lima, MD, Richard E Champlin, MD

Blood (2011) 118 (21): 4460.

https://doi.org/10.1182/blood.V118.21.4460.4460

Published: 2011

Journal Articles

Is There a Role for ASCT in Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum?

Rachel J Cook, MD, MS, Zhiwei Wang, MS, Mukta Arora, MD, Hillard M. Lazarus, MD, Kimberly A. Kasow, DO, Martin A. Champagne, MD, FRCPC, Wael Saber, MD, MS, Koen M. Van Besien, MD, Gregory A. Hale, MD, Edward A. Copelan, MD, Mohamed Elmongy, MD, DSc, Naoto T Ueno, MD, Biljana N. Horn, MD, Shimon Slavin, MD, Edward A. Stadtmauer, MD

Blood (2011) 118 (21): 3092.

https://doi.org/10.1182/blood.V118.21.3092.3092

Published: 2011

Journal Articles

Leukemia-Associated Primary Granule Proteins (PGPs) Elastase-2 and Proteinase-3 Are Aberrantly Expressed in Solid Tumors: A Potential Therapeutic Target for PR1-Directed Immunotherapy

Gheath Alatrash, Luis M Vence, Wendy Woodward, Naoto T Ueno, Jeffrey J Molldrem

Blood (2008) 112 (11): 5440.

https://doi.org/10.1182/blood.V112.11.5440.5440

Published: 2008

Journal Articles

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

Blood (2008) 111 (12): 5530–5536.

https://doi.org/10.1182/blood-2008-01-136242

Published: 2008

Journal Articles

Hepatitis C (HC) Virus Infection Is Associated with Worse Survival after Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT) for Hematological Malignancies.

Carlos A. Ramos, MD, Rima M. Saliba, PhD, Ola Khorshid, MD, Leandro de Padua, MD, Sergio Giralt, MD, Borje S. Andersson, MD, PhD, Naoto T. Ueno, MD, PhD, Elizabeth J. Shpall, MD, Issa F. Khouri, MD, Chitra Hosing, MD, Amin Alousi, MD, Yago Nieto, MD, Suhail R. Qureshi, MD, Richard E. Champlin, MD, Marcos de Lima, MD

Blood (2007) 110 (11): 48.

https://doi.org/10.1182/blood.V110.11.48.48

Published: 2007

Journal Articles

Zevalin®/BEAM/Rituximab vs BEAM/Rituximab and Autologous Stem Cell Transplantation (ASCT) for Relapsed Chemosensitive Diffuse Large B-Cell Lymphoma (DLBCL): Impact of the IPI and PET Status.

Blood (2007) 110 (11): 620.

https://doi.org/10.1182/blood.V110.11.620.620

Published: 2007

Journal Articles

Efficacy and Safety of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan in Autologous and Nonmyeloablative Stem Cell Transplantation (NST) for Relapsed Non-Hodgkin’s Lymphoma (NHL).

Blood (2006) 108 (11): 315.

https://doi.org/10.1182/blood.V108.11.315.315

Published: 2006

Journal Articles

High Doses of CD34+ Cells Chemomobilized with G-CSF PBPC Collection Had Greater CD34(+) Cells Collected Than G-CSF Alone and Trended toward Reduced Progression Rate after Autologous PBPC Transplantation for Breast Cancer in a Phase III Trial.

James L. Gajewski, MD, Rima Saliba, MD, Gabriela Rondon, MD, Naoto T. Ueno, MD, PhD, Michele L. Donato, MD, Paolo Anderlini, MD, Martin Korbling, MD, John D. McMannis, PhD, Sergio A. Giralt, MD, Issa F. Khouri, MD, Rakesh Mehra, MD, Richard E. Champlin, MD

Blood (2004) 104 (11): 5235.

https://doi.org/10.1182/blood.V104.11.5235.5235

Published: 2004

Journal Articles

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

Naoto T. Ueno, Yee Chung Cheng, Gabriela Rondón, Nizar M. Tannir, James L. Gajewski, Daniel R. Couriel, Chitra Hosing, Marcos J. de Lima, Paolo Anderlini, Issa F. Khouri, Daniel J. Booser, Gabriel N. Hortobagyi, Lance C. Pagliaro, Eric Jonasch, Sergio A. Giralt, Richard E. Champlin

Blood (2003) 102 (10): 3829–3836.

https://doi.org/10.1182/blood-2003-04-1022

Published: 2003

Journal Articles

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

Blood (2001) 97 (3): 631–637.

https://doi.org/10.1182/blood.V97.3.631

Published: 2001

Journal Articles

Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Blood Stem Cell Transplantation

Donna Przepiorka, Terry L. Smith, Jody Folloder, Issa Khouri, Naoto T. Ueno, Rakesh Mehra, Martin Körbling, Yang O. Huh, Sergio Giralt, James Gajewski, Michele Donato, Karen Cleary, David Claxton, Ira Braunschweig, Koen van Besien, Borje S. Andersson, Paolo Anderlini, Richard Champlin

Blood (1999) 94 (4): 1465–1470.

https://doi.org/10.1182/blood.V94.4.1465

Published: 1999

NARROW

Donor Leukocyte Infusions (DLIs) for Recurrent Hodgkin Lymphoma (HL) Following Allogeneic Stem Cell Transplantation (allo-SCT): Ten-Year Experience at the M.D. Anderson Cancer Center

Is There a Role for ASCT in Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum?

Leukemia-Associated Primary Granule Proteins (PGPs) Elastase-2 and Proteinase-3 Are Aberrantly Expressed in Solid Tumors: A Potential Therapeutic Target for PR1-Directed Immunotherapy

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

Hepatitis C (HC) Virus Infection Is Associated with Worse Survival after Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT) for Hematological Malignancies.

Zevalin®/BEAM/Rituximab vs BEAM/Rituximab and Autologous Stem Cell Transplantation (ASCT) for Relapsed Chemosensitive Diffuse Large B-Cell Lymphoma (DLBCL): Impact of the IPI and PET Status.

Efficacy and Safety of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan in Autologous and Nonmyeloablative Stem Cell Transplantation (NST) for Relapsed Non-Hodgkin’s Lymphoma (NHL).

High Doses of CD34+ Cells Chemomobilized with G-CSF PBPC Collection Had Greater CD34(+) Cells Collected Than G-CSF Alone and Trended toward Reduced Progression Rate after Autologous PBPC Transplantation for Breast Cancer in a Phase III Trial.

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Blood Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only